Division of Surgical Oncology & Endocrine Surgery


The Division has an extensive basic research program that emphasizes molecular biology and conducts department-sponsored and federally sponsored research in several areas. The basic science research programs of each faculty member are as follows:

  • R. Daniel Beauchamp, MD:
    TGF-beta and Ras signaling in colon cancer, mouse models of colon cancer.
  • Mark C. Kelley, MD:
    Dendritic cell immunotherapy for melanoma, growth factor signaling and molecular targeted therapy for melanoma.
  • A. Scott Pearson, MD:
    Regulation of cell adhesion and tight junctions in colon carcinogenesis.
  • Nipun Merchant, MD:
    EGF signaling in colon cancer, molecular targeted therapy for colon cancer.
  • Ingrid Meszoely, MD:
    DPC4 replacement gene therapy in pancreatic cancer.
  • Ana Grau, MD:
    TGF-beta and Ras signaling in breast cancer.

Each faculty member is also involved in a wide variety of clinical and translational research projects, some of which are conducted as a part of our SPORE grants in GI and breast cancer. There are also a wide variety of projects in all areas of basic cancer biology which are being conducted by faculty members in other clinical and basic science departments.

This page was last updated August 19, 2014 and is maintained by